The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
Abstract
We conducted a randomized, controlled study to assess the need for hydroxychloroquine (HCQ) during lupus pregnancy and to assess safety. Twenty consecutive pregnant patients with similar characteristics were enrolled. The HCQ group included eight patients with systemic lupus erythematosus (SLE) and two with discoid lupus erythematosus (DLE). The placebo (PL) group included nine patients with SLE and one with DLE. The HCQ group had no flare-ups. SLEPDAI scores were similar at study entry, and at conclusion the placebo group had significantly higher scores. One patient had improvement of skin lesions and another of arthritis, allowing a decrease of prednisone dose. There were no retinal effects. Three patients in the PL group flared up, two with skin rashes, one also with arthritis and uveitis, and one (previously in remission on HCQ) with hemolytic anemia, polyserositis and anti-dsDNA antibody. Toxemia was diagnosed in only three patients in the PL group (one fetal death). Comparing prednisone dosage change, we noted a decrease in the HCQ and an increase in the PL group. Delivery age and Apgar scores were higher in the HCQ group. Neonatal examination did not reveal congenital abnormalities, nor did a neuroophthalmological and auditory evaluation at 1.5–3 y of age. In spite of the small number of patients studied, we noted beneficial effects of HCQ during lupus pregnancy, as measured by SLEPDAI and decrease in prednisone dose with no detriment to patients' health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120077042 · Cited by 2,371
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experience
Petri, M., Howard, D., & Repke, J. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341210 · Cited by 390
RUIZ-IRASTORZA, G., LIMA, F., ALVES, J., KHAMASHTA, M. A., SIMPSON, J., HUGHES, G. R. V., & BUCHANAN, N. M. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.2.133 · Cited by 357
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
The Canadian Hydroxychloroquine Study Group, Tsakonas, E., Joseph, L., Esdaile, J. M., Choquette, D., Senécal, J.-L., Cividino, A., Danoff, D., Osterland, C. K., Yeadon, C., et al. (1998) · Lupus · doi:10.1191/096120398678919778 · Cited by 293
Assessing disease activity in SLE patients during pregnancy
Buyon, J. P., Kalunian, K. C., Ramsey-Goldman, R., Petri, M. A., Lockshin, M. D., Ruiz-Irastorza, G., & Khamashta, M. (1999) · Lupus · doi:10.1191/096120399680411272 · Cited by 191
Thrombosis and Systemic Lupus Erythematosus: The Hopkins Lupus Cohort Perspective
Petri, M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069986 · Cited by 176
Antimalarial drugs in the treatment of rheumatological diseases.
Rynes, R. I. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.799 · Cited by 167
Biochemical characterization of ADP-ribose polymer metabolism in SLE
Chen, H.-Y., Pertusi, R., Kirkland, J., Rubin, B., & Jacobson, E. (1996) · Lupus · doi:10.1177/096120339600500105 · Cited by 162
Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
Buchanan, N. M., Toubi, E., Khamashta, M. A., Lima, F., Kerslake, S., & Hughes, G. R. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.7.486 · Cited by 161
Cited by
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study
Buyon, J. P., Kim, M. Y., Guerra, M. M., Laskin, C. A., Petri, M., Lockshin, M. D., Sammaritano, L., Branch, D. W., Porter, T. F., Sawitzke, A., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2235 · Cited by 567
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Metadata
- Authors
- Levy, R. A., Vilela, V. S., Cataldo, M. J., Ramos, R. C., Duarte, J. L., Tura, B. R., Albuquerque, E. M., & Jesús, N. R.
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2001-06
- Volume
- 10
- Issue
- 6
- Pages
- 401-404
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2133925071
- Cited by
- 398
- References
- 17
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. https://app.cochat.ai/papers/10.1191/096120301678646137
- The paper
- Levy, R. A., Vilela, V. S., Cataldo, M. J., Ramos, R. C., Duarte, J. L., Tura, B. R., Albuquerque, E. M., & Jesús, N. R. (2001). Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. https://doi.org/10.1191/096120301678646137
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.